Product Images Theophylline (anhydrous)
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Theophylline (anhydrous) NDC 69367-415 by Westminster Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 400 mg Tablet Bottle Label - theophylline 02
This text describes Extended-Release Tablets containing 400 mg of Theophylline. The recommended dosage is available in the prescribing information. The tablets should be stored at 20° to 25°C (68° to 77°F) in a light-resistant and child-resistant container, as per USP guidelines. A warning to keep medications out of reach of children is also included. The product is presented in 100 Tablets and should be dispensed by prescription only.*
PRINCIPAL DISPLAY PANEL - 600 mg Tablet Bottle Label - theophylline 03
This text contains information about an Extended-Release Tablet containing 600 mg of Theophylline, which is a prescription drug classified as Rx Only. The dosage instructions are not provided in this text, but it recommends referring to accompanying prescribing information. It also mentions to keep the container tightly closed and warns to keep all medications out of reach of children. The tablet is meant to be stored at room temperature. The manufacturer is Westminster Pharmaceuticals, LLC based in Kansas City, MO and Nashville, TN. Additionally, it states "MPP Pharma, LLC" was involved in manufacturing.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.